Trial Site Detail
Drug: |
Ponatinib (Iclusig) |
|||
|---|---|---|---|---|
Trial: |
A Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Knight Cancer Institute at Oregon Health Sciences University (OHSU)3181 S.W. Sam Jackson Park Rd. |
Principal Investigator: |
Michael Heinrich |
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Knight Cancer Institute at Oregon Health Sciences University (OHSU) Website: |
http://www.ohsu.edu/isr/trial_search1.cfm |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.